Spinning Health Solutions from Silk

In 2013, Dr. Ailis Tweed-Kent founded Cocoon Biotech Inc. to come up with a way to treat the actual cause of arthritis, the loss of cartilage in joints. For the therapy, she turned to a biomaterial that has been used for thousands of years: silk.

To read more from STATvisit this page.

Cocoon Selected by Amgen to Receive Lab Space in LabCentral

Amgen and Kendall Square-based LabCentral recently announced Cocoon Biotech as one of two 2015 Golden Ticket winners. The Golden Ticket program provides space and equipment in LabCentral’s facilities for one year to life sciences start-ups with significant potential. Cocoon will soon begin using LabCentral facilities to continue research and development on our novel silk-based treatment. For more information and the full feature on the Golden Ticket selection, visit this page.